Accéder au contenu
Merck

Crystal Structure of Ripk4 Reveals Dimerization-Dependent Kinase Activity.

Structure (London, England : 1993) (2018-05-01)
Christine S Huang, Nina Oberbeck, Yi-Chun Hsiao, Peter Liu, Adam R Johnson, Vishva M Dixit, Sarah G Hymowitz
RÉSUMÉ

Receptor-interacting protein kinase 4 (RIPK4) is a highly conserved regulator of epidermal differentiation. Members of the RIPK family possess a common kinase domain as well as unique accessory domains that likely dictate subcellular localization and substrate preferences. Mutations in human RIPK4 manifest as Bartsocas-Papas syndrome (BPS), a genetic disorder characterized by severe craniofacial and limb abnormalities. We describe the structure of the murine Ripk4 (MmRipk4) kinase domain, in ATP- and inhibitor-bound forms. The crystallographic dimer of MmRipk4 is similar to those of RIPK2 and BRAF, and we show that the intact dimeric entity is required for MmRipk4 catalytic activity through a series of engineered mutations and cell-based assays. We also assess the impact of BPS mutations on protein structure and activity to elucidate the molecular origins of the disease.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Millipore
Gel d'affinité ANTI-FLAG® M2, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Anticorps monoclonal ANTI-FLAG® M2-peroxydase (HRP) antibody produced in mouse, clone M2, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
CEP-701 hydrate, ≥98% (HPLC)